Latest News - Opthea

Wednesday, August 16, 2017 | Retina, AMD, Opthea

New Anti-VEGF Drug Promising for Wet Macular Degeneration

A new antivascular endothelial growth-factor (VEGF) drug, OPT-302 (Opthea), appears to be safe and shows signs of effectiveness in the treatment of neovascular age-related macular degeneration, new re…

Read the full story

Thursday, July 06, 2017 | Patents, Opthea

Opthea Receives Notice of Allowance for Key Patent Covering OPT-302 Eye Disease Drug in the United States

Opthea announced that it has received a Notice of Allowance from the United States Patent and Trade Mark Office for the company's Patent Application No. 14/768,701 for its OPT-302 soluble VEGFR-3 …

Read the full story